J9370 HCPCS code: Vincristine sulfate, 1 mg
J9370 is the HCPCS Level II code for vincristine sulfate, 1 mg. In 2024 Medicare paid an average of $6.26 per service for J9370 across 17,212 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 4 per day on DME suppliers. Medicare volume fell 34% from 2022 to 2024 (26,102 to 17,212 services). In 2024, 3 suppliers billed Medicare for J9370 (purchases), serving 0 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 1986-01-01 |
| Last action effective | 1997-01-01 |
Who bills J9370 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 3 |
| Referring clinicians | 6 |
| Medicare beneficiaries | 0 |
| States with claims | 2 |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 4 | 0 |
| 2023 | 4 | 0 |
| 2024 | 3 | 0 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9370, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 26,102 | 3,826 | $4.84 | $3.86 |
| 2023 | 21,032 | 3,214 | $6.04 | $4.80 |
| 2024 | 17,212 | 2,685 | $7.88 | $6.26 |
States with the most J9370 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 2,054 | $6.26 |
| California | 1,975 | $6.27 |
| Texas | 1,818 | $6.29 |
| Illinois | 951 | $6.26 |
| Virginia | 825 | $6.27 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 4 | Clinical: Data |
| outpatient hospital claims | 4 | Clinical: Data |
| practitioner claims | 4 | Clinical: Data |
What changed for J9370
- 1986-01-01: J9370 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9370?
J9370 is the HCPCS Level II code for vincristine sulfate, 1 mg. Short descriptor: "Vincristine sulfate 1 mg inj".
How much does Medicare pay for J9370?
In 2024, the average Medicare payment was $6.26 per service (average allowed $7.88).
Does Medicare cover J9370?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J9370 can be billed per day?
4 on DME suppliers; 4 on outpatient hospital claims; 4 on practitioner claims (NCCI medically unlikely edits).
Related J93 codes
- J9300 — Injection, gemtuzumab ozogamicin, 5 mg
- J9301 — Injection, obinutuzumab, 10 mg
- J9302 — Injection, ofatumumab, 10 mg
- J9303 — Injection, panitumumab, 10 mg
- J9304 — Injection, pemetrexed (pemfexy), 10 mg
- J9305 — Injection, pemetrexed, not otherwise specified, 10 mg
- J9306 — Injection, pertuzumab, 1 mg
- J9307 — Injection, pralatrexate, 1 mg
- J9308 — Injection, ramucirumab, 5 mg
- J9309 — Injection, polatuzumab vedotin-piiq, 1 mg
- J9310 — Injection, rituximab, 100 mg
- J9311 — Injection, rituximab 10 mg and hyaluronidase
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9370
- Watch J9370 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9370
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.